Inhalon Biopharma

Inhalon Biopharma

  • Founded: 2018
  • Location: Morrisville, NC
  • Employee range: 1 - 10
  • Clinical stage: Clin1
  • Therapy area: COVID-19
  • Drug types: INF
  • Lead product: IN-006
  • Product link:
  • Funding: 10-100M

job board

Short description:


Drug notes:

IN-002 Clin0 RSV; undisclosed RD metapneumovirus; undisclosed RD parainfluenza

Long description:

Inhalon Biopharma is a clinical-stage biotechnology company developing revolutionary inhaled antibody treatments for acute respiratory infections (ARIs). The company's unique science is based on its proprietary muco-trapping antibody platform, which targets and binds viruses and bacteria in mucus, the protective lining of the airways. This innovative approach enables direct and localized treatment of respiratory infections, potentially preventing the spread of pathogens and reducing the severity of symptoms.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy